E Frei

7.9k total citations · 2 hit papers
104 papers, 6.1k citations indexed

About

E Frei is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, E Frei has authored 104 papers receiving a total of 6.1k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Oncology, 37 papers in Pulmonary and Respiratory Medicine and 30 papers in Molecular Biology. Recurrent topics in E Frei's work include Cancer Treatment and Pharmacology (22 papers), Acute Lymphoblastic Leukemia research (19 papers) and Lung Cancer Treatments and Mutations (18 papers). E Frei is often cited by papers focused on Cancer Treatment and Pharmacology (22 papers), Acute Lymphoblastic Leukemia research (19 papers) and Lung Cancer Treatments and Mutations (18 papers). E Frei collaborates with scholars based in United States, India and Germany. E Frei's co-authors include Norman Jaffe, Demetrius Traggis, Robert J. Mayer, O. Ross McIntyre, Yvonne Bishop, Sylvia A. Holden, Charles A. Schiffer, Joseph O. Moore, Bayard L. Powell and George Omura and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

E Frei

104 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Intensive Postremission Chemotherapy in Adults with Acute Myeloid Leukemia

1994 1.0k citations E Frei et al. New England Journal of Medicine profile →
Adjuvant Methotrexate and Citrovorum-Factor Treatment of Osteogenic Sarcoma

1974 360 citations E Frei, Demetrius Traggis et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
E Frei United States	42	2.2k	1.8k	1.6k	1.3k	1.2k	104	6.1k
E. Wiltshaw United Kingdom	43	2.8k 1.2×	1.4k 0.8×	1.2k 0.8×	686 0.5×	1.4k 1.2×	129	7.4k
Roy B. Jones United States	43	2.5k 1.1×	970 0.5×	3.4k 2.2×	880 0.7×	765 0.6×	176	6.6k
Martin F. Fey Switzerland	49	3.0k 1.3×	3.1k 1.7×	2.1k 1.3×	868 0.7×	955 0.8×	189	8.0k
Jon P. Gockerman United States	36	1.5k 0.7×	836 0.5×	1.1k 0.7×	574 0.4×	636 0.5×	128	4.4k
Thomas C. Shea United States	38	2.5k 1.1×	1.6k 0.9×	1.8k 1.2×	563 0.4×	935 0.8×	172	5.6k
Robert K. Stuart United States	39	2.0k 0.9×	2.0k 1.1×	3.4k 2.2×	900 0.7×	637 0.5×	198	6.9k
Robert L. Capizzi United States	37	1.2k 0.5×	1.3k 0.7×	922 0.6×	976 0.7×	630 0.5×	134	4.0k
M. Schneider France	38	2.8k 1.3×	1.0k 0.6×	1.2k 0.8×	420 0.3×	1.3k 1.1×	108	5.8k
K. Höffken Germany	36	2.6k 1.2×	1.1k 0.6×	855 0.5×	424 0.3×	848 0.7×	186	5.4k
Louise B. Grochow United States	32	4.0k 1.8×	1.3k 0.7×	897 0.6×	556 0.4×	1.5k 1.2×	59	6.6k

Countries citing papers authored by E Frei

Since Specialization

Citations

This map shows the geographic impact of E Frei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E Frei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E Frei more than expected).

Fields of papers citing papers by E Frei

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E Frei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E Frei. The network helps show where E Frei may publish in the future.

Co-authorship network of co-authors of E Frei

This figure shows the co-authorship network connecting the top 25 collaborators of E Frei. A scholar is included among the top collaborators of E Frei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E Frei. E Frei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Richardson, Paul G., David Avigan, Joseph G. Ibrahim, et al.. (2001). A short course of induction chemotherapy followed by two cycles of high-dose chemotherapy with stem cell rescue for chemotherapy naive metastatic breast cancer: sequential phase I/II studies. Bone Marrow Transplantation. 28(5). 447–454. 4 indexed citations

Frei, E, et al.. (1998). Chemopreventive effects of dithiocarbamates on aflatoxin B1 metabolism and formation of AFB1 adducts with glutathione.. PubMed. 18(3A). 1827–32. 8 indexed citations

Teicher, Beverly A., et al.. (1996). Postlabeling detection of DNA adducts of antitumor alkylating agents. Cancer Chemotherapy and Pharmacology. 38(1). 71–80. 1 indexed citations

Ayash, Lois, C Wheeler, Diane L. Fairclough, et al.. (1995). Prognostic factors for prolonged progression-free survival with high-dose chemotherapy with autologous stem-cell support for advanced breast cancer.. Journal of Clinical Oncology. 13(8). 2043–2049. 99 indexed citations

Elias, Anthony, Arthur T. Skarin, R Gonin, et al.. (1994). Neoadjuvant Treatment of Stage IIIA Non-Small Cell Lung Cancer Long-Term Results. American Journal of Clinical Oncology. 17(1). 26–36. 28 indexed citations

Elias, Anthony, Lois Ayash, I Tepler, et al.. (1993). The Use of G-CSF or GM-CSF Mobilized Peripheral Blood Progenitor Cells (PBPC) Alone or to Augment Marrow as Hematologic Support of Single or Multiple Cycle High-Dose Chemotherapy. Journal of Hematotherapy. 2(3). 377–382. 8 indexed citations

Frei, E, Sylvia A. Holden, René Gonin, David J. Waxman, & Beverly A. Teicher. (1993). Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies. Cancer Chemotherapy and Pharmacology. 33(2). 113–122. 19 indexed citations

Elias, Anthony, Lois Ayash, Arthur T. Skarin, et al.. (1993). High-Dose Combined Alkylating Agent Therapy With Autologous Stem Cell Support and Chest Radiotherapy for Limited Small-Cell Lung Cancer. CHEST Journal. 103(4). 433S–435S. 8 indexed citations

Wright, Joel E., et al.. (1993). Methotrexate andγ-tert-butyl methotrexate transport in CEM and CEM/MTX human leukemic lymphoblasts. Biochemical Pharmacology. 46(5). 871–876. 6 indexed citations

10.

Teicher, B A, et al.. (1991). Lonidamine as a modulator of alkylating agent activity in vitro and in vivo.. PubMed. 51(3). 780–4. 35 indexed citations

11.

Elias, Anthony, Lois Ayash, J. P. Eder, et al.. (1991). Escalating doses of carboplatin with high-dose ifosfamide using autologous bone marrow as support: a phase I study. Journal of Cancer Research and Clinical Oncology. 117(S4). S208–S213. 6 indexed citations

12.

Teicher, Beverly A., Terence S. Herman, Lawrence N. Shulman, et al.. (1991). Combination of etanidazole with cyclophosphamide and platinum complexes. Cancer Chemotherapy and Pharmacology. 28(3). 153–158. 11 indexed citations

13.

Goorin, Allen M., Herbert T. Abelson, & E Frei. (1985). Osteosarcoma: Fifteen Years Later. New England Journal of Medicine. 313(26). 1637–1643. 142 indexed citations

14.

Jaffe, N, et al.. (1983). Osteogenic sarcoma: alterations in the pattern of pulmonary metastases with adjuvant chemotherapy.. Journal of Clinical Oncology. 1(4). 251–254. 77 indexed citations

15.

Kufe, DW, Patrick M. Beardsley, Daniel D. Karp, et al.. (1980). High-dose thymidine infusions in patients with leukemia and lymphoma.. Blood. 55(4). 580–9. 42 indexed citations

16.

Sallan, SE, et al.. (1978). Intermittent combination chemotherapy with adriamycin for childhood acute lymphoblastic leukemia: clinical results.. Blood. 51(3). 425–33. 100 indexed citations

17.

Ensminger, William D. & E Frei. (1977). The prevention of methotrexate toxicity by thymidine infusions in humans.. PubMed. 37(6). 1857–63. 74 indexed citations

18.

Jaffe, N, Demetrius Traggis, J. Robert Cassady, et al.. (1976). Multidisciplinary treatment for macrometastatic osteogenic sarcoma.. BMJ. 2(6043). 1039–1041. 19 indexed citations

19.

Frei, E. (1967). Some Thoughts On Adjuvant Cancer Chemotherapy. CA A Cancer Journal for Clinicians. 17(5). 226–229. 1 indexed citations

20.

Calabresi, Paul, et al.. (1962). Summary of current information on 6-azauridine.. PubMed. 21. 1–18. 43 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact